News | June 13, 2013

Mirada Medical PET/MRI Software is Highlighted in Multiple Research Studies

Mirada’s software PET/MRI is an alternative to hybrid scanners

June 13, 2013 — Mirada Medical collaborators presentnew positron emission tomography/magnetic resonance imaging (PET/MRI) research.

PET/MRI is a rapidly developing field and Mirada is working to provide the software tools to support the research and trials necessary to realize the potential of the new modality in molecular imaging. The software supports both the hardware hybrid scanners and provides validated deformable registration for software based PET/CT(computed tomorgraphy)/MRI.

David Townsend, professor and director of the A*STAR-NUS Clinical Imaging Research Centre (CIRC) in Singapore, recently presented a paper entitled “Initial results of the assessment of PET/MR compared to PET/CT for diagnosis and staging of malignant disease.” This work is a comparative analysis of the image quality and quantification accuracy of hardware PET/MRI and PET/CT, a highly relevant topic of current interest in the field. Advanced quantification features and accurate deformable registration in Mirada PET/MRI software allowed the quantification of regions-of-interest simultaneously in both the PET/MRI and PET/CT of the same patient.

Another quantification analysis is presented in the work of Dr.Thomas Klausen of Rigshospitalet, Denmark, entitled “Image distortions and bias from dental restorations in PET/CT- and PET/MR-imaging.” In this work, Mirada’s support for multiple studies and multiple sequences enabled the analysis of artifacts arising from dental fillings on image quality and quantification on hardware PET/MRI and PET/CT.

Mirada’s software PET/MRI is an alternative to hybrid scanners and is based on deformable registration between the PET/CT and MRI to perform the fusion. A high-quality registration is critical for effective fusion between PET/CT and MRI. Mirada’s deformable registration algorithm, is the subject of another paper by Dr. Martin Lodge of Johns Hopkins University entitled “Combined PET/CT/MRI of the pelvis using software registration.” This work investigates the accuracy of the deformable registration between the CT and MR in the pelvis.

For more information: www.mirada-medical.com

 

Related Content

News | Business | September 19, 2017
September 19, 2017 — Invicro LLC, a provider of imaging services and software for research and drug development, anno
ScImage and Invia Partnership Announced
News | PACS | September 19, 2017
ScImage Inc. and Invia Imaging Solutions recently announced formation of a joint partnership at the American Society of...
Toshiba Highlights Latest CT Advancements at RSNA 2017
News | Computed Tomography (CT) | September 18, 2017
Toshiba Medical announced that it will display several new enhancements to its existing computed tomography (CT)...
Philips Launches CardioMD IV Cardiac SPECT Solution at ASNC 2017
Technology | SPECT Imaging | September 15, 2017
September 15, 2017 — Philips highlighted its newest solution for...
Double Targeting Ligands to Identify and Treat Prostate Cancer

The mice were imaged with small-animal PET/CT using 124I-RPS-027 (7.4 MBq [200 μCi]). Credit: JM Kelly et al., Department of Radiology, Weill Cornell Medicine, New York, NY

News | Prostate Cancer | September 14, 2017
Researchers have demonstrated a new, effective way to precisely identify and localize prostate cancer tumors while...
Blue Earth Diagnostics Announcing Results of FALCON PET/CT Trial at ASTRO 2017
News | PET-CT | September 13, 2017
September 13, 2017 — Blue Earth Diagnostics announced the upcoming oral presentation of initial results from the FALC
FDG-PET/CT Predicts Melanoma Patients' Response to Immune Checkpoint Inhibitor Therapy
News | PET-CT | September 07, 2017
September 7, 2017 — Advanced melanoma has a poor prognosis, but immune checkpoint inhibitor therapy can be effective
German Team Optimizing Therapy Planning for Cancers of the Liver
News | Interventional Radiology | August 29, 2017
Radioembolization is a therapy method used for liver tumors that are uncurable with surgery or chemotherapy. Thorough...
Sponsored Content | Videos | Nuclear Imaging | August 24, 2017
Prem Soman, M.D., director of nuclear cardiology at the Heart and Vascular Institute, University of Pittsburgh, and p
Overlay Init